Celestica, Inc. (NYSE:CLS – Get Free Report) (TSE:CLS)’s stock price rose 3.4% on Thursday. The stock traded as high as $377.65 and last traded at $373.5650. Approximately 2,804,641 shares traded hands during trading, an increase of 16% from the average daily volume of 2,425,590 shares. The stock had previously closed at $361.43.
Analysts Set New Price Targets
A number of analysts recently issued reports on CLS shares. Stifel Nicolaus set a $500.00 price target on shares of Celestica in a report on Tuesday, July 28th. Wolfe Research lifted their price objective on shares of Celestica from $425.00 to $475.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. TD set a $430.00 price objective on shares of Celestica and gave the stock a “buy” rating in a research report on Wednesday, September 16th. Zacks Research lowered shares of Celestica from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 28th. Finally, UBS Group upgraded Celestica from a “neutral” rating to a “buy” rating and raised their target price for the company from $410.00 to $430.00 in a research report on Monday, August 24th. Twenty-three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $450.50.
View Our Latest Report on Celestica
Celestica Stock Performance
Celestica (NYSE:CLS – Get Free Report) (TSE:CLS) last posted its quarterly earnings data on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, topping analysts’ consensus estimates of $2.29 by $0.25. Celestica had a net margin of 7.16% and a return on equity of 39.96%. The company had revenue of $4.68 billion during the quarter, compared to analysts’ expectations of $4.30 billion. During the same period in the prior year, the business posted $1.39 earnings per share. The firm’s revenue for the quarter was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. As a group, research analysts predict that Celestica, Inc. will post 10.71 EPS for the current fiscal year.
Insider Activity at Celestica
In related news, CEO Robert Mionis sold 98,453 shares of Celestica stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total value of $36,328,172.47. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Mandeep Chawla sold 16,117 shares of Celestica stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $369.32, for a total value of $5,952,330.44. Following the completion of the sale, the chief financial officer owned 65,444 shares in the company, valued at approximately $24,169,778.08. The trade was a 19.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 243,067 shares of company stock valued at $89,200,967. 1.10% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Celestica
Hedge funds and other institutional investors have recently made changes to their positions in the company. Renaissance Technologies LLC purchased a new stake in shares of Celestica during the first quarter worth $68,952,000. Quantinno Capital Management LP raised its position in shares of Celestica by 73.7% in the first quarter. Quantinno Capital Management LP now owns 23,954 shares of the technology company’s stock valued at $6,746,000 after buying an additional 10,164 shares during the last quarter. K.J. Harrison & Partners Inc acquired a new stake in shares of Celestica in the second quarter valued at about $1,092,000. Ninepoint Partners LP purchased a new position in shares of Celestica in the second quarter worth about $2,880,000. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of Celestica by 1.9% in the first quarter. The Manufacturers Life Insurance Company now owns 959,586 shares of the technology company’s stock worth $270,416,000 after buying an additional 18,105 shares in the last quarter. Hedge funds and other institutional investors own 67.38% of the company’s stock.
About Celestica
Celestica Inc (NYSE: CLS) is a global provider of design, manufacturing, and supply-chain services for original equipment manufacturers and other technology companies. The company helps customers develop, produce, deploy, and support complex hardware and electronic systems, serving industries such as communications, enterprise technology, aerospace and defense, industrial technology, health care, and semiconductor equipment.
Its services include product design and engineering, printed circuit board and systems assembly, manufacturing, testing, logistics, aftermarket support, and supply-chain management.
Further Reading
- Five stocks we like better than Celestica
- MarketBeat Week in Review – 09/28 – 10/02
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
